The association between endocrine disrupting chemicals and MAFLD: Evidence from NHANES survey

Abstract

Previous studies on the association of endocrine-disrupting chemicals (EDCs) with metabolic dysfunction-associated fatty liver disease (MAFLD) are very limited. This study analyzed the association of EDCs exposure with MAFLD among 5073 American adults from the 2017–2018 National Health and Nutrition Examination Survey. The results showed that increased exposure to 3 EDCs metabolites (namely As, DiNP and PFOA) were significantly associated with MAFLD, the odds ratio of which were 1.819 (95% CI: 1.224, 2.702), 1.959 (95% CI: 1.224, 3.136) and 2.148 (95% CI: 1.036, 4.456), respectively. Further, the bayesian kernel machine regression model also revealed that phthalates exposure was strongly connected with the MAFLD, particularly in females and the elderly over 65. Moderating effect analysis suggested that higher body mass index (BMI) and inflammatory diet habit (indicated by dietary inflammatory index) strengthened the association between EDCs and MAFLD, whereas population with higher level of insulin sensitivity showed lower risk. In conclusion, our results suggest that either single or combined exposure to EDCs metabolites is link to MAFLD. Our findings also encourage people to sustain a healthy diet, normal levels of insulin sensitivity and BMI, which may help to alleviate the association of MAFLD risk in exposure to EDCs. These results also help us to better understand the association of EDCs and MAFLD and provide effective evidences for preventing MAFLD from the EDCs exposure aspect.

Keywords

• Endocrine disrupting chemicals
• Metabolic dysfunction-associated fatty liver disease
• Phthalates
• Perfluoroalkyl and polyfluoroalkyl substances
• NHANES